Literature DB >> 27285946

Health Economic Impact of a Pulmonary Artery Pressure Sensor for Heart Failure Telemonitoring: A Dynamic Simulation.

Peter L Kolominsky-Rabas1,2, Christine Kriza1,2, Anatoli Djanatliev3, Florian Meier4, Steffen Uffenorde5, Jannis Radeleff5, Philipp Baumgärtel6, Ines Leb7, Martin Sedlmayr7, Sebastian Gaiser8, Philip B Adamson9.   

Abstract

AIMS: Recently, a permanently implantable wireless system, designed to monitor and manage pulmonary artery (PA) pressures remotely, demonstrated significant reductions in heart failure (HF) hospitalizations in high-risk symptomatic patients, regardless of ejection fraction. The objectives of this study were to simulate the estimated clinical and economic impact in Germany of generalized use of this PA pressure monitoring system considering reductions of HF hospitalizations and the improvement in Quality of Life.
MATERIALS AND METHODS: Based on the Prospective Health Technology Assessment approach, we simulated the potential of the widespread application of PA pressure monitoring on the German healthcare system for the period 2009-2021.
RESULTS: This healthcare economic simulation formulated input assumptions based on results from the CHAMPION Trial, a multicenter, prospective, randomized controlled U.S. trial that demonstrated a 37% reduction of hospitalizations in persistently symptomatic previous HF patients. Based on these results, an estimated 114,800 hospitalizations would expected to be avoided. This effect would potentially save an estimated €522 million, an equivalent of $575 million, during the entire simulation period.
CONCLUSION: This healthcare economic modeling of the PA pressure monitoring system's impact demonstrates substantial clinical and economic benefits in the German healthcare system.

Entities:  

Keywords:  cardiology/cardiovascular disease; home health monitoring; telecardiology; telehealth; telemedicine

Mesh:

Year:  2016        PMID: 27285946     DOI: 10.1089/tmj.2015.0226

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  6 in total

1.  Cost-Effectiveness of Remote Cardiac Monitoring With the CardioMEMS Heart Failure System.

Authors:  Jordana K Schmier; Kevin L Ong; Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2017-03-08       Impact factor: 2.882

2.  Based Real Time Remote Health Monitoring Systems: A Review on Patients Prioritization and Related "Big Data" Using Body Sensors information and Communication Technology.

Authors:  Naser Kalid; A A Zaidan; B B Zaidan; Omar H Salman; M Hashim; H Muzammil
Journal:  J Med Syst       Date:  2017-12-29       Impact factor: 4.460

Review 3.  Effect of recombinant human brain natriuretic peptide (rhBNP) versus nitroglycerin in patients with heart failure: A systematic review and meta-analysis.

Authors:  Sijie Zhang; Zhiqian Wang
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

Review 4.  Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature.

Authors:  Maarten J IJzerman; Hendrik Koffijberg; Elisabeth Fenwick; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2017-07       Impact factor: 4.981

5.  Cost-of-illness studies in heart failure: a systematic review 2004-2016.

Authors:  Wladimir Lesyuk; Christine Kriza; Peter Kolominsky-Rabas
Journal:  BMC Cardiovasc Disord       Date:  2018-05-02       Impact factor: 2.298

6.  Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.

Authors:  Xuecheng Zhao; Da-Qi Zhang; Rongjing Song; Guoqiang Zhang
Journal:  J Int Med Res       Date:  2020-01       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.